Cargando…
In vitro Inhibition of Canine Complement‐Mediated Hemolysis
BACKGROUND: Immune‐mediated hemolytic anemia (IMHA) is the most common hematologic immune‐mediated disease in dogs. Complement fixation on erythrocytes causes hemolysis. Complement inhibition decreases hemolysis in people with the hemolytic disease and also may prove effective in treating IMHA in do...
Autores principales: | Hernandez, D.M., Goggs, R., Behling‐Kelly, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787187/ https://www.ncbi.nlm.nih.gov/pubmed/29171101 http://dx.doi.org/10.1111/jvim.14871 |
Ejemplares similares
-
Effect of dilution of canine blood samples on the specificity of saline agglutination tests for immune‐mediated hemolysis
por: Sun, Prudence L., et al.
Publicado: (2020) -
Acute phase protein response and changes in lipoprotein particle size in dogs with systemic inflammatory response syndrome
por: Behling‐Kelly, Erica, et al.
Publicado: (2022) -
C(1) inhibitor in canine intravascular hemolysis (C(1)INCH): study protocol for a randomized controlled trial
por: Goggs, Robert, et al.
Publicado: (2019) -
Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma
por: Thamm, D.H., et al.
Publicado: (2017) -
The Effect of Urine Concentration and pH on the Growth of Escherichia Coli in Canine Urine In Vitro
por: Thornton, L.A., et al.
Publicado: (2018)